4
A fresh ultimatum demanding «binding commitments» to lower U.S. drug prices sent pharma firms scrambling Friday.
Trump’s drug price ultimatum sets pharma firms scrambling
WSJ Membership
- The Journal Collection
- Subscription Options
- Why Subscribe?
- Corporate Subscriptions
- WSJ Higher Education Program
- WSJ High School Program
- Public Library Program
- WSJ Live
- Commercial Partnerships
Customer Service
- Customer Center
- Contact Us
- Cancel My Subscription
Tools & Features
- Newsletters & Alerts
- Guides
- Topics
- My News
- RSS Feeds
- Video Center
- Watchlist
- Podcasts
- Visual Stories
Ads
- Advertise
- Commercial Real Estate Ads
- Place a Classified Ad
- Sell Your Business
- Sell Your Home
- Recruitment & Career Ads
- Digital Self Service
More
- About Us
- Content Partnerships
- Corrections
- Jobs at WSJ
- News Archive
- Register for Free
- Reprints & Licensing
- Buy Issues
- WSJ Shop
- Dow Jones Press Room
- Dow Jones Smart Money
